Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of Propranolol Between 6 and 12 Months of Age in High-Risk Infantile Hemangioma.
Baselga E, Dembowska-Baginska B, Przewratil P, González-Enseñat MA, Wyrzykowski D, Torrelo A, López Gutiérrez JC, Rychłowska-Pruszyńska M, de Lucas-Laguna R, Esteve-Martinez A, Roé E, Zaim M, Menon Y, Gautier S, Lebbé G, Bouroubi A, Delarue A, Voisard JJ. Baselga E, et al. Among authors: delarue a. Pediatrics. 2018 Sep;142(3):e20173866. doi: 10.1542/peds.2017-3866. Epub 2018 Aug 6. Pediatrics. 2018. PMID: 30082451 Clinical Trial.
A randomized, controlled trial of oral propranolol in infantile hemangioma.
Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, Phillips RJ, Caceres H, Lopez Gutierrez JC, Ballona R, Friedlander SF, Powell J, Perek D, Metz B, Barbarot S, Maruani A, Szalai ZZ, Krol A, Boccara O, Foelster-Holst R, Febrer Bosch MI, Su J, Buckova H, Torrelo A, Cambazard F, Grantzow R, Wargon O, Wyrzykowski D, Roessler J, Bernabeu-Wittel J, Valencia AM, Przewratil P, Glick S, Pope E, Birchall N, Benjamin L, Mancini AJ, Vabres P, Souteyrand P, Frieden IJ, Berul CI, Mehta CR, Prey S, Boralevi F, Morgan CC, Heritier S, Delarue A, Voisard JJ. Léauté-Labrèze C, et al. Among authors: delarue a. N Engl J Med. 2015 Feb 19;372(8):735-46. doi: 10.1056/NEJMoa1404710. N Engl J Med. 2015. PMID: 25693013 Free article. Clinical Trial.
Safety of Propranolol Therapy for Severe Infantile Hemangioma.
Prey S, Voisard JJ, Delarue A, Lebbe G, Taïeb A, Leaute-Labreze C, Ezzedine K. Prey S, et al. Among authors: delarue a. JAMA. 2016 Jan 26;315(4):413-5. doi: 10.1001/jama.2015.13969. JAMA. 2016. PMID: 26813215 No abstract available.
Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations.
Del Frari L, Léauté-Labrèze C, Guibaud L, Barbarot S, Lacour JP, Chaumont C, Delarue A, Voisard JJ, Brunner V. Del Frari L, et al. Among authors: delarue a. Pharmacol Res Perspect. 2018 Apr 30;6(3):e00399. doi: 10.1002/prp2.399. eCollection 2018 Jun. Pharmacol Res Perspect. 2018. PMID: 29736244 Free PMC article.
Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial.
Stockfleth E, Jouary T, Farnetani F, Pascual AM, De Almeida Agudo C, Voisard JJ, Bégeault N, Delarue A. Stockfleth E, et al. Among authors: delarue a. Dermatol Ther (Heidelb). 2023 Apr;13(4):1013-1027. doi: 10.1007/s13555-023-00902-6. Epub 2023 Mar 1. Dermatol Ther (Heidelb). 2023. PMID: 36856965 Free PMC article.
112 results